BURLINGTON, N.C., Nov. 4, 2026 /PRNewswire/ -- Labcorp (NYSE:LH), a global leader of innovative and comprehensive laboratory services, announced today that Chief Financial Officer Julia Wang will speak at the UBS Global
Results from operations for third quarter 2026 versus third quarter 2025:Revenue: $3.81 billion vs. $3.56 billion, up 6.9%Diluted EPS: $3.22 vs. $3.12, up 3.3%Adjusted EPS: $4.78 vs. $4.18, up 14.5%Raised full-year
Labcorp intends to be the first commercial laboratory to offer FDA-approved HPV testing with the BD Onclarity™ HPV Assay across clinician-collected and self-collected screening options in clinic, patient service center,
Research collaboration aims to strengthen the science used to assess whether new medicines could be abused, supporting safer drug development and more informed regulatory decisionsBURLINGTON, N.C., Oct. 22, 2026
BURLINGTON, N.C., Oct. 21, 2026 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE:LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash
SALT LAKE CITY and BURLINGTON, N.C., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostic testing and precision medicine, and Labcorp (NYSE:LH), a global leader in
Acquisition will expand access to clinical laboratory services, including a broad specialty testing menu for patients and providers nationwideBURLINGTON, N.C. and MIAMI, Fla., Oct. 15, 2026 /PRNewswire/ --
First lab test offered in collaboration with Thrive GlobalCombines Labcorp's scientific expertise with Thrive Global's behavior change approach to help consumers turn health insights into healthier daily
BURLINGTON, N.C., Sept. 30, 2026 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE:LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the third quarter of 2026
Reaffirms full-year 2026 guidanceProvides long-term outlook through 2029, with compound annual revenue growth of 5% to 8% and compound annual adjusted earnings per share (EPS) growth of 8.5% to 11.5%Outlines strategic
NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, Sept. 9, 2026 /CNW/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access
Acquisition establishes Labcorp as the only central laboratory provider with a wholly owned laboratory network across four continentsBURLINGTON, N.C., Sept. 8, 2026 /PRNewswire/ -- Labcorp (NYSE:LH), a global leader of
Enhanced digital experience designed to improve visibility, simplify workflows and support faster decision-makingBURLINGTON, N.C., Aug. 31, 2026 /PRNewswire/ -- Labcorp (NYSE:LH), a global leader of innovative and
BURLINGTON, N.C., Aug. 28, 2026 /PRNewswire/ -- Labcorp (NYSE:LH), a global leader of innovative and comprehensive laboratory services, announced today that members of the executive management team will participate in a
Elecsys® pTau-217 is the first and only FDA-cleared single-biomarker blood test to both rule in and rule out amyloid pathology across specialty and primary care settingsMeasures phosphorylated Tau 217 (pTau-217), an
